The results showed that at 6 months post immunization, antibody levels declined, while memory T cells and B cells were comparatively stable, and similar levels of CD4 and CD8 T cell responses were observed between mRNA and protein-based COVID-19 vaccines. The gene discussed is CD8A; the disease is COVID-19.